Statistics
A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: First-in-human trial of ChAd63-KH
| Views | |
|---|---|
| A ... | 1675 |
Total Visits Per Month
| December 2025 | January 2026 | February 2026 | March 2026 | April 2026 | May 2026 | June 2026 | |
|---|---|---|---|---|---|---|---|
| A ... | 35 | 33 | 25 | 38 | 40 | 18 | 5 |
File Visits
| Views | |
|---|---|
| 29FL5e9GFDkgQ.pdf | 664 |